CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial have?
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial has 331 citations in the OpenAlex counts ScholarIQ stores.
When was CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial published?
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial has 2018 year in the ScholarIQ index.
What is the open-access status of CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial?
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial has gold oa status in the ScholarIQ index.
What is the DOI of CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial?
The DOI for CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial is on the source record.
What is the PMID of CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial?
The PMID for CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial is on the source record.
What is the OpenAlex record for CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial?
The OpenAlex for CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial is on the source record.